Cargando…

First evaluation of hydroxychloroquine recommendations in treating SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Roussel, Y., Raoult, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508006/ https://www.ncbi.nlm.nih.gov/pubmed/32983541 http://dx.doi.org/10.1016/j.nmni.2020.100759

Ejemplares similares

Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
por: Million, Matthieu, et al.
Publicado: (2021)

Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.
por: Gautret, Philippe, et al.
Publicado: (2021)

Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann
por: Gautret, Philippe, et al.
Publicado: (2021)

Hydroxychloroquine serum concentrations in non-critical care patients infected with SARS-CoV-2
por: MacGowan, Alasdair, et al.
Publicado: (2021)

Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data
por: Grandvuillemin, Aurélie, et al.
Publicado: (2020)

Screening for SARS-CoV-2 antibodies to save vaccine doses
por: Fenollar, Florence, et al.
Publicado: (2022)

Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.
por: Million, Matthieu, et al.
Publicado: (2021)

Slit-lamp evaluation during SARS-CoV-2 pandemic: safety first!
por: Ruiz-Lozano, Raul E., et al.
Publicado: (2020)

Response to: Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis
por: Boglione, Lucio, et al.
Publicado: (2021)

Evidence of SARS-CoV-2 re-infection with a different genotype
por: Colson, Philippe, et al.
Publicado: (2021)

Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19
por: Colson, Philippe, et al.
Publicado: (2021)

Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load
por: Nguyen, Tuan V.
Publicado: (2021)

Lack of viral clearance by the combination of hydroxychloroquine and azithromycin or lopinavir and ritonavir in SARS-CoV-2-related acute respiratory distress syndrome
por: Hraiech, Sami, et al.
Publicado: (2020)

Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis – Authors reply
por: Kumar, Jogender, et al.
Publicado: (2021)

High rate of reinfection with the SARS-CoV-2 Omicron variant
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for ImmunoTherapy of Cancer (FITC)
por: Gauci, Marie-Léa, et al.
Publicado: (2021)

Does SARS-CoV-2 re-infection depend on virus variant?
por: Gautret, Philippe, et al.
Publicado: (2021)

Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not?
por: Keikha, Masoud
Publicado: (2022)

Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not?
por: Keikha, Masoud
Publicado: (2022)

Profile of specific antibodies to SARS-CoV-2: The first report
por: Xiao, Ai Tang, et al.
Publicado: (2020)

Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
por: Gautret, Philippe, et al.
Publicado: (2021)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

First case of monkeypox virus, SARS-CoV-2 and HIV co-infection
por: Nolasco, Santi, et al.
Publicado: (2023)

SARS-CoV-2: a general recommendation to adhere to government regulations cannot be evidence-based
por: Kampf, G., et al.
Publicado: (2021)

Physical activity and mobile applications, recommendations for remote workers during the SARS-CoV-2 pandemic
por: Cruz-Ausejo, Liliana, et al.
Publicado: (2021)

Control of SARS-CoV-2 infection in rituximab-treated neuroimmunological patients
por: Woo, Marcel S., et al.
Publicado: (2020)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

Guillain–Barré syndrome as the first manifestation of SARS-CoV-2 infection
por: Barrachina-Esteve, O., et al.
Publicado: (2020)

Re: Profile of specific antibodies to SARS-CoV-2: The first report
por: Zeng, Zhikun, et al.
Publicado: (2020)

Bilateral cystoid maculopathy as first manifestation of SARS-CoV-2 infection
por: Stanescu-Segall, D., et al.
Publicado: (2021)

A first probable case of SARS-CoV-2 reinfection in Colombia
por: Novoa, Whilken, et al.
Publicado: (2021)

Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Assay for the Detection of SARS-CoV-2 in Oropharyngeal Swab Specimens
por: Hou, Hongyan, et al.
Publicado: (2020)

Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases
por: Trefond, Ludovic, et al.
Publicado: (2021)

SARS-CoV-2 and dentistry
por: Ortega, Karem L., et al.
Publicado: (2020)

SARS-CoV-2 in cardiomyocytes
por: Finsterer, Josef
Publicado: (2021)

Pharmacotherapeutics of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Hydroxychloroquine + azithromycin treatment in elderly patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Lichen planus after SARS-CoV-2 infection treated with lopinavir/ritonavir()
por: Gimeno Castillo, Javier, et al.
Publicado: (2021)

Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab
por: Vellas, Camille, et al.
Publicado: (2022)

Reinfection by SARS-CoV-2: The first one in a family reported in Spain
por: Aguilar-Shea, Antonio L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iia77gti7clc6cd0r01aog6o0k